The Swedish initiative for the study of Primary sclerosing cholangitis (SUPRIM)Research in context

Summary: Background: Despite more than 50 years of research and parallel improvements in hepatology and oncology, there is still today neither a treatment to prevent disease progression in primary sclerosing cholangitis (PSC), nor reliable early diagnostic tools for the associated hepatobiliary can...

Descrición completa

Detalles Bibliográficos

Principais autores:	Martin Cornillet, Christina Villard, Fredrik Rorsman, Antonio Molinaro, Emma Nilsson, Stergios Kechagias, Erik von Seth, Annika Bergquist
Formato:	Artigo
Idioma:	Inglês
Publicado:	Elsevier 2024-04-01
Series:	EClinicalMedicine
Assuntos:	Primary sclerosing cholangitis Inflammatory bowel disease Liver transplantation Phenotype Outcome
Acceso en liña:	http://www.sciencedirect.com/science/article/pii/S2589537024001056
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!